RAPP (Rapport Therapeutics, Inc. Common Stock) Stock Financials & Earnings

RAPPRapport Therapeutics, Inc. Common Stock

Mkt Cap$1B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$111M

EPS (TTM)-$2.30

Free Cash Flow (TTM)-$88M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$15K	-$5M
Q2 23	$0	-$21K	-$7M
Q3 23	$0	$0	-$10M
Q4 23	$0	-$76K	-$15M
Q1 24	$0	-$152K	-$17M
Q2 24	$0	-$208K	-$21M
Q3 24	$0	$0	-$22M
Q4 24	$0	$0	-$24M
Q1 25	$0	$0	-$27M
Q2 25	$0	$0	-$29M
Q3 25	$0	$0	-$30M
Q4 25	$0	$0	-$39M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$70M	$77M	$147M
Q1 24	$74M	$119M	$193M
Q2 24	$110M	$226M	$336M
Q3 24	$39M	$281M	$321M
Q4 24	$57M	$248M	$305M
Q1 25	$58M	$228M	$285M
Q2 25	$55M	$205M	$260M
Q3 25	$251M	$262M	$513M
Q4 25	$53M	$438M	$491M

Shares Outstanding

Revenue Per Employee

Revenue / Employee